Azepinone as a conformational constraint in the design of κ-opioid receptor agonists
- 15 November 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (22) , 5693-5697
- https://doi.org/10.1016/j.bmcl.2004.08.041
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Peripherally Restricted Opioid Agonists as Novel Analgesic AgentsCurrent Pharmaceutical Design, 2004
- Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitisPain, 2003
- Arylacetamides as peripherally restricted kappa opioid receptor agonistsBioorganic & Medicinal Chemistry Letters, 2000
- Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root gangliaNeuroscience, 1998
- Novel developments with selective, non-peptidic kappa-opioid receptor agonistsExpert Opinion on Investigational Drugs, 1997
- Analgesic Efficacy of Enadoline Versus Placebo or Morphine in Postsurgical PainClinical Neuropharmacology, 1996
- Analgesic Efficacy of the κ-Receptor Agonist, Enadoline, in Dental Surgery PainClinical Neuropharmacology, 1996
- Selective non-peptide kappa opioid receptor agonistsExpert Opinion on Investigational Drugs, 1994
- 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid .kappa. agonistsJournal of Medicinal Chemistry, 1991
- A novel series of potent and selective agonists at the opioid κ-receptorEuropean Journal of Pharmacology, 1988